Procedure

2016 discharge: IMI 2 Joint Undertaking

2017/2184(DEC)·8th term·CONT·DEC - Discharge procedure·Completed

Subjects: 2016 discharge

Rapporteur (the Member appointed to lead Parliament's work on this text): HAYES Brian (PPE)

Summary

This dossier concerns the 2016 discharge for the IMI 2 Joint Undertaking. The amendments postpone the discharge decision for the Executive Director of the Innovative Medicines Initiative 2 Joint Undertaking, note payment appropriations below 75%, the implementation of Horizon 2020 funds and industry in-kind and cash contributions, the anti-fraud strategy, delays in payments to beneficiaries including universities, research organisations and SMEs, and involvement in the Horizon 2020 mid-term review.

Amendments

distinct, in window

Members

tabled at least one

Committee

1 Mar 2018

Dates